CRBP
Corbus Pharmaceuticals Holding
5.90$
-4.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.5% | +3.0% | +31.6% | -48.8% | +42.7% | -44.5% | -34.6% | -5.7% | -978.0% | – | +4.1% | – | |
| – | -2.7% | +22.9% | +31.2% | +74.1% | -27.2% | +5.0% | -8.8% | +1.2% | -9.7% | +34.1% | -5.7% | – | |
| – | -46.0% | -250.3% | – | -514.8% | – | – | – | +4,951.6% | -37.8% | -212.3% | – | – | |
| – | +0.0% | -33.3% | +0.0% | +0.0% | -100.0% | – | – | – | – | -14.3% | +0.0% | – | |
| – | -4.7% | -1,045.6% | -83.3% | -6.5% | – | +107.6% | -2.1% | +10.7% | -391.0% | – | -18.7% | – | |
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | |
| – | +132.0% | – | -67.2% | -28.4% | -100.1% | -100.0% | – | – | +2,515.7% | – | – | – | |
| – | -14.7% | -84.7% | +2,428.5% | -144.5% | – | – | -32.8% | +506.6% | -78.3% | -306.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.